Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2007

Conditions
Eating DisordersBulimia Nervosa
Interventions
DRUG

Baclofen

Participants will take baclofen 3 times a day, before meals, for 10 weeks. Baclofen dosages will be low to begin, followed by a gradual increase over a 2-week period. Upon reaching the maximum tolerated dose of baclofen, participants will continue at this dosage level until Week 11, at which time the dose will be gradually decreased. If any serious side effects occur, baclofen dosage will be decreased to the previous tolerated dosage level.

Trial Locations (1)

10032

Eating Disorders Clinic, New York State Psychiatric Institute, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00320047 - Effectiveness of Baclofen in the Treatment of People With Bulimia Nervosa or Binge Eating Disorder | Biotech Hunter | Biotech Hunter